U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07526662) titled 'Maternal-Fetal Heart Sound/Electrocardiogram Monitoring and Cardiac Risk Early Warning' on April 03.
Brief Summary: This is a prospective observational cohort study conducted at Beijing Anzhen Hospital. The study aims to establish reference ranges of heart sound and electrocardiogram (ECG) parameters for both mothers and fetuses. It seeks to develop early warning models for maternal adverse cardiac events, fetal congenital heart disease progression, and autoimmune-related fetal heart block, thereby building a comprehensive maternal-fetal integrated risk stratification system.
Study Start Date: May, 2026
Study Type: OBSERVATIONAL...